Tag
Roche
- Genmab A/S reports 51% lower progression or death risk in Phase 3 lymphoma trial
- Merck says remigromig met BRUNELLO vision endpoint, flags eye risks
- Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test
- Cancer detection specialist Freenome lists on Nasdaq through special purpose merger
- Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug
- Roche collaboration to accelerate Freenome’s blood-based cancer screening
- Early detection breakthrough means pancreatic cancer could be diagnosed in minutes
- Moffitt adopts PathAI AISight Dx to drive cancer care innovation
- Australian biotech uncovers broader view of tumour genetics with liquid biopsy
- Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump
- TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
- New drug could open personalized treatment strategies for prostate cancer